Euro Genetic Engineering 2020

About Conference


Conference Series LLC Ltd insist participants from all over the universe to “Annual Congress on Genetics engineering-Insight-2020” during December 14-15, 2020 Tokyo, Japan. which includes precise keynote, presentations Oral talks, Poster presentation and Exhibitions. The theme of the conference this year is “Exploring Current Challenges In Cells and Gene Therapy” assures an exceptional scientific program promoting many acclaimed and logic tormenting speakers.

Genetics engineering-insight-2020 Conference is dedicated platform for all physical therapists and occupational Therapists. Physical  therapists working as a clinicians, managers, researchers, students or educators to share their knowledge and experiences in the field of physical therapy and occupational therapy and to network with colleagues from around the world and interact with international leaders in their field.

Conference Series LLC Ltd  organizes a conference series of 1000+ Global Events inclusive of 500+ Conferences, 500+ Upcoming and Previous Symposiums and Workshops in the USA, Europe & Asia with support from 1000 more scientific societies and publishes 700+ Open access journals which contain over 30000 eminent personalities, reputed scientists as editorial board members.

Conference Highlights
  • Current Genetic Engineering Discoveries  
  • Genetically Modified Crops and Food  
  • Gene Therapy, IVF, Stem Cells, and Pharmacogenomics 
  • Genetic Change and Mutations  
  • Molecular Cloning and Gene Delivery 
  • Genetically Modified Organisms  
  • Plasmid Architecture and Vector Drug Discovery Technologies  
  • Clinical Genetics  
  • DNA Fingerprint and Diagnostics  
  • Genetic Diagnosis and Disease Risks  
  • CRISPR Gene Editing  
  • Stem Cells and Cloning  
  • Industrial Biotechnology 
  • Medicinal Biotechnology

Special Issues
 -  All accepted abstracts will be published in respective OMICS International Journals.
 -  Abstracts will be provided with Digital Object Identifier by Cross Ref.

No comments:

Post a Comment